Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rhenium-188P2045 by Andarix Pharmaceuticals for Squamous Non-Small Cell Lung Carcinoma: Likelihood of Approval
Rhenium-188P2045 is under clinical development by Andarix Pharmaceuticals and currently in Phase II for Squamous Non-Small Cell Lung Carcinoma. According...